Improve-it trial summary
WitrynaIMPROVE-IT(Improved Reduction of Outcomes: Vytorin Efficacy International Trial [进一步降低终点事件:葆至能疗效国际试验])是一项在 急性冠脉综合征 的高危患者中 … Witryna[The IMPROVE-IT trial] [The IMPROVE-IT trial] [The IMPROVE-IT trial] G Ital Cardiol (Rome). 2015 Dec;16(12):667-71. doi: 10.1714/2088.22578. [Article in Italian] Authors …
Improve-it trial summary
Did you know?
WitrynaThe Trial Summary (TS) domain is a trial-level dataset that allows for the submission of a high-level view of a study in a structured format. Each record contains the value of a parameter or characteristic of the trial. It is used to record basic information about the study such as trial phase, protocol title, and trial objectives. Witryna1 lis 2008 · The IMPROVE-IT trial has become even more important since the release of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial results, 24 which compared the effects the combination of ezetimibe and high-dose simvastatin with high-dose simvastatin alone on carotid …
Witryna18 cze 2015 · When added to statin therapy, ezetimibe resulted in incremental lowering of LDL cholesterol levels and improved cardiovascular outcomes. Moreover, lowering LDL cholesterol to levels below previous targets provided additional benefit. (Funded by Merck; IMPROVE-IT ClinicalTrials.gov number, NCT0020287 … Witryna5 godz. temu · This article summaries discussions involving academia, the pharmaceutical industry, patient groups, and government agencies held during a 2024 US Food and Drug Administration (FDA) workshop to improve the regulatory and clinical trial infrastructure necessary to develop antifungals for invasive fungal infections. …
WitrynaSummary The Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) was a large double-blind, randomised controlled trial to investigate … WitrynaOther trials have shown that digital adherence technologies (SMS-based and those based on medication event reminder monitors), implemented in real-time, can …
Witryna19 lis 2014 · Con IMPROVE IT finalmente ha aparecido el estudio clínicamente relevante sobre la reducción de los niveles de colesterol con ezetimibe añadido a una estatina (simvastatina, estatina de moderada intensidad según las guías mencionadas), en el que se ha demostrado una mejoría pronóstica a pesar de partir con unos niveles LDL …
Witryna19 lis 2014 · IMPROVE IT posiblemente inducirá algún cambio en las guías en futuras revisiones. Otra posibilidad es que pueda ayudar a evitar la posibilidad de … portland event space with projectorWitrynaThe Pravastatin or Atorvastatin Evaluation and Infection Therapy trial (PROVE-IT/TIMI-22) showed that in patients with acute coronary syndromes, aggressive lipid-lowering using atorvastatin 80 mg/day provided greater protection against death or major cardiovascular events than did moderate lipid-low … Lessons from the PROVE-IT trial. optician newarthillWitryna14 kwi 2024 · Recent reviews of the science of child development have identified the need to include “direct assessments of the brain” in trials, in part to improve … portland events in march 2022WitrynaTrial Summary: Opioid vs NonopioidSingle Dose Medications for Acute Extremity Pain in the Emergency Department (ED) May 2024 Opioid Tapering Q&A Patient Booklet Apr 2024 Non-Live Recombinant Herpes Zoster Vaccine (SHINGRIX) 2024 Nov 2024 Exercise Rx(pdf) Nov 2024 Exercise Rx(Word) Nov 2024 optician nearbyWitrynaRationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of … optician near meoptician newarkWitrynaFindings In a prespecified analysis of 15 281 patients enrolled in IMPROVE-IT, patients achieving an LDL-C level of less than 30 mg/dL at 1 month after acute coronary … portland events and festivals